Generic Drugs: Guidelines for Bioequivalence Studies - Pushpendra Kumar Vishwakarma - Grāmatas - VDM Verlag Dr. Müller - 9783639343779 - 2011. gada 2. jūnijs
Ja vāks un nosaukums nesakrīt, pareizs ir nosaukums

Generic Drugs: Guidelines for Bioequivalence Studies


Saņemt e-pastu, kad prece būs pieejama
Do you have a profile? Pierakstīties
Saņemiet paziņojumus par jauniem Pushpendra Kumar Vishwakarma izdevumiem
Pievienot savam iMusic vēlmju sarakstam

Not rated yet

A generic drug (generic drugs, short: generics) is a drug which is produced and distributed without patent protection. The generic drug may still have a patent on the formulation but not on the active ingredient. A generic must contain the same active ingredients as the original formulation. According to the U. S. Food and Drug Administration (FDA), generic drugs are identical or bioequivalent to the brand name counterpart with respect to pharmacokinetic and pharmacodynamic properties. By extension, therefore, generics are identical in dose, strength, route of administration, safety, efficacy, and intended use. In most cases, generic products are available once the patent protections afforded to the original developer have expired. When generic products become available, the market competition often leads to substantially lower prices for both the original brand name product and the generic forms. The time it takes a generic drug to appear on the market varies.

Mediji Grāmatas     Paperback Book   (Grāmata ar mīksto vāku un līmēto muguru)
Izlaists 2011. gada 2. jūnijs
ISBN13 9783639343779
Izdevēji VDM Verlag Dr. Müller
Lapas 148
Izmēri 150 × 9 × 226 mm   ·   226 g
Valoda Angļu  

Vairāk no tā paša izdevēja